TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

[27] We consider the use of a single-dose intravenous salbutamol bolus in the ED to be more effective in achieving earlier clinical response in a subgroup of children with acute severe asthma.

TNKase is delivered as a single five-second intravenous bolus. This is considerably faster than the standard of care, ...

compared the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in hospitalized general medical patients with type 2 diabetes. The prospective ...

The FDA approved a one-time, five-minute IV bolus infusion of tenecteplase for ... Ophthalmology and Internal Medicine at Genentech, told Healio. “This milestone strengthens our commitment ...